New hope for glucokinase activators in type 2 diabetes?

André J Scheen

Journal: The lancet. Diabetes & endocrinology 2019;6(8):591-593

PMID: 29735393

Full Text on Elsevier Science View on PubMed

Abstract

Address: Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, Academic Hospital of Liège, Liège, Belgium; Division of Clinical Pharmacology, Centre for Interdisciplinary Research on Medicines, University of Liège, Liège B-4000, Belgium. Electronic address: [email protected].

DOI: 10.1016/S2213-8587(18)30133-5

Link outs

Free resources

Medical:

https://medlineplus.gov/diabetestype2.html

Other Literature Sources:

https://scite.ai/reports/29735393

Subscription / membership required

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S2213...
https://www.clinicalkey.com/content/playBy/pii?v=S...

MeSH Terms: Blood Glucose, Diabetes Mellitus, Type 2, Double-Blind Method, Glucokinase, Humans, Hypoglycemic Agents